Keyphrases
Clinical Outcomes
100%
Vaccine Responsiveness
100%
Hepatitis B Vaccine
100%
Non-controllers
100%
HIV Controllers
100%
Highly Active Antiretroviral Therapy (HAART)
63%
Nave
36%
Vaccination
27%
Vaccine Response
27%
Viral Load
18%
CD4 Count
18%
Hepatitis B Surface Antigen (HBsAg)
18%
Vaccine Dose
18%
Progression to AIDS
18%
Clinical Characteristics
9%
Risk Reduction
9%
HIV Patients
9%
Non-responders
9%
Natural History Study
9%
Antibody to Hepatitis B Core Antigen
9%
US Military
9%
Immunological Characteristics
9%
Responder Status
9%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Hepatitis B Vaccine
100%
Hepatitis B Virus
46%
Virus Vaccine
38%
Viral Load
15%
CD4 Lymphocyte Count
15%
Hepatitis B Surface Antibody
15%
HBsAg
7%
Hepatitis B Antigen
7%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Hepatitis B Vaccine
100%
Hepatitis B Virus
46%
Virus Vaccine
38%
Hepatitis B Antibody
15%
Hepatitis B Antigen
7%
Administered Dose
7%
Veterinary Science and Veterinary Medicine
Hepatitis B
100%
Hepatitis B Vaccine
100%
Acquired Immune Deficiency Syndrome
57%
CD4
28%
Chemical Engineering
HIV
100%
Human immunodeficiency virus
100%